Perfluoroctamethylcuban | 50782-50-8

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机氟化物
• 英文名称: Perfluoroctamethylcuban
• 英文别名: 1,2,3,4,5,6,7,8-Octakis(trifluoromethyl)cubane
• CAS: 50782-50-8
• 化学式: C₁₆F₂₄
• 分子量: 648.138
• InChiKey: QVRDMSYXLGQMGE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.9
• 重原子数：
  40
• 可旋转键数：
  0
• 环数：
  6.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  24

文献信息

• SUBLIMABLE SUSTAINED RELEASE DELIVERY SYSTEM AND METHOD OF MAKING SAME
  申请人：Oakwood Laboratories L.L.C.

  公开号：EP1962586A2

  公开（公告）日：2008-09-03
• SUBLIMABLE SUSTAINED RELEASE DEIVERLY SYSTEM AND METHOD OF MAKING SAME
  申请人：Maskiewicz Richard

  公开号：US20070148098A1

  公开（公告）日：2007-06-28

  The invention relates to compositions suitable for the delivery and/or stabilization of biologically active substances. The compositions comprise a sublimable matrix material and the biologically active agent to be delivered. The compositions can be used as drug delivery systems to treat a wide variety of diseases or as systems for the protection and stabilization of such substances. Also disclosed are methods for preparing compositions of the present invention.
• US8987340B2
  申请人：——

  公开号：US8987340B2

  公开（公告）日：2015-03-24
• US9301919B2
  申请人：——

  公开号：US9301919B2

  公开（公告）日：2016-04-05
• [EN] SUBLIMABLE SUSTAINED RELEASE DELIVERY SYSTEM AND METHOD OF MAKING SAME<br/>[FR] SYSTEME A LIBERATION LENTE SUBLIMABLE ET SON PROCEDE DE FABRICATION
  申请人：OAKWOOD LAB LLC

  公开号：WO2007076462A2

  公开（公告）日：2007-07-05

  [EN] The invention relates to compositions suitable for the delivery and/or stabilization of biologically active substances. The compositions comprise a sublimable matrix material and the biologically active agent to be delivered. The compositions can be used as drug delivery systems to treat a wide variety of diseases or as systems for the protection and stabilization of such substances. Also disclosed are methods for preparing compositions of the present invention.
  [FR] L'invention concerne des compositions appropriées pour la libération et/ou la stabilisation de substances biologiquement actives. Les compositions contiennent un matériau matriciel sublimable et l'agent biologiquement actif destiné à être libéré. Les compositions peuvent être utilisées en tant que systèmes de libération de médicaments afin de traiter une large gamme de maladies ou en tant que systèmes de protection et de stabilisation desdites substances. L'invention concerne également des procédés de préparations des compositions selon l'invention.